BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7496796)

  • 1. Intra-VTA injections of the mu-opioid antagonist CTOP enhance locomotor activity.
    Badiani A; Leone P; Stewart J
    Brain Res; 1995 Aug; 690(1):112-6. PubMed ID: 7496796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
    Chieng B; Connor M; Christie MJ
    Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    Devine DP; Leone P; Pocock D; Wise RA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumbal core: essential link in feed-forward spiraling striato-nigro-striatal in series connected loop.
    Ikeda H; Koshikawa N; Cools AR
    Neuroscience; 2013 Nov; 252():60-7. PubMed ID: 23933312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential conditioned place preference responses to endomorphin-1 and endomorphin-2 microinjected into the posterior nucleus accumbens shell and ventral tegmental area in the rat.
    Terashvili M; Wu HE; Leitermann RJ; Hung KC; Clithero AD; Schwasinger ET; Tseng LF
    J Pharmacol Exp Ther; 2004 May; 309(2):816-24. PubMed ID: 14755004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists.
    Devine DP; Leone P; Wise RA
    Eur J Pharmacol; 1993 Oct; 243(1):55-64. PubMed ID: 7902813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats.
    Hyytiä P; Kiianmaa K
    Alcohol Clin Exp Res; 2001 Jan; 25(1):25-33. PubMed ID: 11198711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and neurochemical effects of opioids in the paramedian midbrain tegmentum including the median raphe nucleus and ventral tegmental area.
    Klitenick MA; Wirtshafter D
    J Pharmacol Exp Ther; 1995 Apr; 273(1):327-36. PubMed ID: 7714785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulations of mu-opioid and nicotinic cholinergic receptors in the pontine tegmental region alter cocaine self-administration in rats.
    Corrigall WA; Coen KM; Adamson KL; Chow BL
    Psychopharmacology (Berl); 1999 Aug; 145(4):412-7. PubMed ID: 10460318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reciprocal opioid-opioid interactions between the ventral tegmental area and nucleus accumbens regions in mediating mu agonist-induced feeding in rats.
    Bodnar RJ; Lamonte N; Israel Y; Kandov Y; Ackerman TF; Khaimova E
    Peptides; 2005 Apr; 26(4):621-9. PubMed ID: 15752577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mu opioid agonist DAMGO alters the intravenous self-administration of cocaine in rats: mechanisms in the ventral tegmental area.
    Corrigall WA; Coen KM; Adamson KL; Chow BL
    Psychopharmacology (Berl); 1999 Feb; 141(4):428-35. PubMed ID: 10090651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of delta and mu opioid receptors in mediating the effects of enkephalins on avoidance conditioning.
    Schulteis G; Martinez JL
    Psychopharmacology (Berl); 1992; 109(1-2):157-62. PubMed ID: 1365650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased food intake after opioid microinjections into nucleus accumbens and ventral tegmental area of rat.
    Mucha RF; Iversen SD
    Brain Res; 1986 Nov; 397(2):214-24. PubMed ID: 3026557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens.
    MacDonald AF; Billington CJ; Levine AS
    Brain Res; 2004 Aug; 1018(1):78-85. PubMed ID: 15262208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
    Izenwasser S; Búzás B; Cox BM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus.
    Klitenick MA; Kalivas PW
    J Pharmacol Exp Ther; 1994 Apr; 269(1):437-48. PubMed ID: 8169850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a mu-opioid-opioid connection between the paraventricular nucleus and ventral tegmental area in the rat.
    Quinn JG; O'Hare E; Levine AS; Kim EM
    Brain Res; 2003 Nov; 991(1-2):206-11. PubMed ID: 14575893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats.
    Matsuzaki S; Ikeda H; Akiyama G; Sato M; Moribe S; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuropharmacology; 2004 Jun; 46(8):1089-96. PubMed ID: 15111015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventral tegmental area opioid mechanisms and modulation of ingestive behavior.
    Badiani A; Leone P; Noel MB; Stewart J
    Brain Res; 1995 Jan; 670(2):264-76. PubMed ID: 7743190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.